RxDoctor Payments Data

Justin Daigre, MD

Foot and Ankle Surgery · Decatur, ALNPI 1215198007

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $225,906 of the $371,930 with a category attached, or 60.7%. 16 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 59.9% of the total. Among foot and ankle surgery clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$371,930in general payments, 2019–2025

Across 356 payments — averaging $1044.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$223K
  • Linvatec Corporation$95K
  • In2bones USA, LLC$39K
  • DJO, LLC$6K
  • Arthrex$4K
  • Stryker$2K
  • plus $2K from 10 others
$65,181in research payments, 2019–2025

Across 68 payments — averaging $958.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Treace Medical Concepts, Inc.$65K

What the payments were for

  • Royalty or licence$8,1912%
  • Consulting fees$225,90661%
  • Speaking & faculty fees$20,3595%
  • Grants$7,5002%
  • Travel & lodging$48,75313%
  • Food & beverage$7,8922%
  • Education$1,1640%
  • Other$52,16514%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$371,930 in reported general payments places this provider in the 95th percentile of 40 foot and ankle surgery providers in Alabama.

See all foot and ankle surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$198,156
Medicare patients
452
Services billed
5,496

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate74$542
Methylprednisolone50$359
Gabapentin36$231
Meloxicam82$205
Alendronate Sodium20$190
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$143
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$141
Cephalexin13$61
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim15$56

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Decatur

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →